Genetics Generation Advancement Corp.TPEX: 4160

Genetics Generation Advancement To announce that 2021 Consolidated Financial Statement approved by the Board of Directors

· Issued by Genetics Generation Advancement Corp.
Close
Today's Information

Provided by: Genetics Generation Advancement Corp.(GGA Cor
SEQ_NO 3 Date of announcement 2022/03/17 Time of announcement 20:58:07
Subject
 To announce that 2021 Consolidated Financial
Statement approved by the Board of Directors
Date of events 2022/03/17 To which item it meets paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/03/17
2.Date of the audit committee approved:2022/03/17
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):519,511
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):195,494
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):(4,529)
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):10,197
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):8,008
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):7,839
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.32
11.Total assets end of the period (thousand NTD):424,757
12.Total liabilities end of the period
(thousand NTD):106,061
13.Equity attributable to owners of parent end of the
period (thousand NTD):318,916
14.Any other matters that need to be specified:None

Earlier from Genetics Generation Advancement

All Genetics Generation Advancement news releases